T-Cell NK-Cell Engaging Bispecific Antibodies and Forecast Market

List of Tables
Table 1. Key Players of T-Cell & NK-Cell Engaging Bispecific Antibodies in Global Market
Table 2. Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market, Ranking by Revenue (2021)
Table 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Companies, 2017-2022
Table 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Companies, (ml), 2017-2022
Table 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Price (2017-2022) & (US$/ml)
Table 8. Global Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Product Type
Table 9. List of Global Tier 1 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2017-2022
Table 15. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2023-2028
Table 16. By Application ? Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2017-2022
Table 20. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2023-2028
Table 21. By Region ? Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2017-2022
Table 25. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2023-2028
Table 26. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2017-2022
Table 29. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2023-2028
Table 30. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2017-2022
Table 33. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2023-2028
Table 34. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2017-2022
Table 37. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2023-2028
Table 38. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2017-2022
Table 41. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2023-2028
Table 42. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2017-2022
Table 45. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2023-2028
Table 46. AbbVie Corporate Summary
Table 47. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 48. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 49. Astellas Pharma Corporate Summary
Table 50. Astellas Pharma T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 51. Astellas Pharma T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 52. GEMoaB Monoclonals Corporate Summary
Table 53. GEMoaB Monoclonals T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 54. GEMoaB Monoclonals T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 55. Immunocore Corporate Summary
Table 56. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 57. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 58. Molecular Partners Corporate Summary
Table 59. Molecular Partners T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 60. Molecular Partners T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 61. Roche Corporate Summary
Table 62. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 63. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 64. AstraZeneca Corporate Summary
Table 65. AstraZeneca T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 66. AstraZeneca T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 67. Merck & Co. Corporate Summary
Table 68. Merck & Co. T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 69. Merck & Co. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 70. Pfizer Corporate Summary
Table 71. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 72. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 73. Eli Lilly Corporate Summary
Table 74. Eli Lilly T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 75. Eli Lilly T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 76. IGM Biosciences Corporate Summary
Table 77. IGM Biosciences T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 78. IGM Biosciences T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 79. Novartis Corporate Summary
Table 80. Novartis T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 81. Novartis T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 82. BenHealth Biopharmaceuticals Corporate Summary
Table 83. BenHealth Biopharmaceuticals T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 84. BenHealth Biopharmaceuticals T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 85. CytomX Therapeutics Corporate Summary
Table 86. CytomX Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 87. CytomX Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 88. Janssen Corporate Summary
Table 89. Janssen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 90. Janssen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 91. Lava Therapeutics Corporate Summary
Table 92. Lava Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 93. Lava Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 94. MacroGenics Corporate Summary
Table 95. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 96. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 97. Maverick Therapeutics Corporate Summary
Table 98. Maverick Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 99. Maverick Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 100. VBL Therapeutics Corporate Summary
Table 101. VBL Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 102. VBL Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 103. Amgen Corporate Summary
Table 104. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 105. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2017-2022)
Table 106. T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity (ml) of Key Manufacturers in Global Market, 2020-2022 (ml)
Table 107. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Capacity Market Share of Key Manufacturers, 2020-2022
Table 108. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region, 2017-2022 (ml)
Table 109. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region, 2023-2028 (ml)
Table 110. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Opportunities & Trends in Global Market
Table 111. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers in Global Market
Table 112. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints in Global Market
Table 113. T-Cell & NK-Cell Engaging Bispecific Antibodies Raw Materials
Table 114. T-Cell & NK-Cell Engaging Bispecific Antibodies Raw Materials Suppliers in Global Market
Table 115. Typical T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream
Table 116. T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream Clients in Global Market
Table 117. T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors and Sales Agents in Global Market
List of Figures
Figure 1. T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Type
Figure 2. T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Application
Figure 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028 (US$, Mn)
Figure 7. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Global Market: 2017-2028 (ml)
Figure 8. The Top 3 and 5 Players Market Share by T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue in 2021
Figure 9. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 10. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 11. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/ml), 2017-2028
Figure 12. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 13. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 14. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/ml), 2017-2028
Figure 15. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 16. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 17. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 18. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 19. US T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 20. Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 23. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 24. Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 25. France T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 27. Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 28. Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 32. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 33. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 34. Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 37. India T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 39. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 40. Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 44. Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 45. Israel T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 47. UAE T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 48. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity (ml), 2017-2028
Figure 49. The Percentage of Production T-Cell & NK-Cell Engaging Bispecific Antibodies by Region, 2021 VS 2028
Figure 50. T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Value Chain
Figure 51. Marketing Channels